Physician profile
Simhadri M Gupta
NPI 1760483895
$2,701.64
in general payments reported to CMS, 2019-2025
22 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $273 · 2021: $652 · 2022: $556 · 2023: $136 · 2024: $658 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.51 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,179.82 | 2019-2025 | Vumerity, Tysabri |
| Lilly USA, LLC | $348.61 | 2023-2025 | Kisunla, Amyvid |
| Eisai INC. | $198.04 | 2022-2024 | |
| Sk Life Science, INC. | $153.14 | 2021-2022 | |
| Celgene Corporation | $150.15 | 2020-2023 | Zeposia |
| Abbott Laboratories | $139.55 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $118.63 | 2020-2024 | Uplizna |
| Genentech USA, INC. | $113.48 | 2020-2023 | Ocrevus |
| Emd Serono, INC. | $66.50 | 2022 | |
| Grifols USA, LLC | $42.29 | 2019-2021 | |
| Avion Pharmaceuticals | $30.55 | 2023 | Dhivy |
| Argenx US, INC. | $18.73 | 2025 | Vyvgart Hytrulo |
| Arbor Pharmaceuticals, INC. | $16.25 | 2021 | |
| Pfizer INC. | $16.23 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $16.23 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.34 | 2020 | |
| Kyowa Kirin, INC. | $14.14 | 2021 | |
| Mdd US Operations, LLC | $14.13 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.15 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.92 | 2022 | |
| Acorda Therapeutics, INC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simhadri Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.